Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| Tamsulosin | IC50 | 4.8 [1] | |
| Methyl 5-[3-(4,4-diphenylpiperidin-1-yl)propylcarbamoyl]-2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3-carboxylate | Ki | 269.0 [1] | |
| Doxazosin | Ki | 0.63 [1], 0.74 [2], 0.81 [3], 1.0 [4] | |
| 3-[2-[4-(2-Methoxyphenyl)-1-piperazinyl]ethyl]-1,5-dihydropyrimido[5,4-b]indole-2,4-dione | Ki | 1.82 [1] | |
| N-((1r,4r)-4-(4-(2-Cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide | Ki | 133.0 [1], 141.0 [2] | |
MLA | "Quest Database™ Alpha-1b adrenergic receptor Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 4 Dec. 2025, https://www.aatbio.com/data-sets/alpha-1b-adrenergic-receptor-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 4). Quest Database™ Alpha-1b adrenergic receptor Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/alpha-1b-adrenergic-receptor-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |